BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 33868267)

  • 1. Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children.
    de Armas LR; George V; Filali-Mouhim A; Steel C; Parmigiani A; Cunningham CK; Weinberg A; Trautmann L; Sekaly RP; Cameron MJ; Pahwa S
    Front Immunol; 2021; 12():639358. PubMed ID: 33868267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to pandemic ASO3-adjuvanted A/California/07/09 H1N1 influenza vaccine in human immunodeficiency virus-infected individuals.
    Kelly D; Burt K; Missaghi B; Barrett L; Keynan Y; Fowke K; Grant M
    BMC Immunol; 2012 Aug; 13():49. PubMed ID: 22937824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of
    de Armas LR; Cotugno N; Pallikkuth S; Pan L; Rinaldi S; Sanchez MC; Gonzalez L; Cagigi A; Rossi P; Palma P; Pahwa S
    J Immunol; 2017 Mar; 198(5):1995-2005. PubMed ID: 28130496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.
    Pariani E; Boschini A; Amendola A; Poletti R; Anselmi G; Begnini M; Ranghiero A; Cecconi G; Zanetti AR
    Vaccine; 2011 Nov; 29(49):9209-13. PubMed ID: 21974995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals.
    Powell AM; Luo Z; Martin L; Wan Z; Ma L; Liao G; Song Y; Li X; Michael Kilby J; Huang L; Jiang W
    Vaccine; 2017 Feb; 35(5):831-841. PubMed ID: 28017428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of activation-induced deaminase (AID) expression with antibody response to A(H1N1)pdm09 vaccination in HIV-1 infected patients.
    Cagigi A; Pensieroso S; Ruffin N; Sammicheli S; Thorstensson R; Pan-Hammarström Q; Hejdeman B; Nilsson A; Chiodi F
    Vaccine; 2013 Apr; 31(18):2231-7. PubMed ID: 23499520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.
    Crum-Cianflone NF; Iverson E; Defang G; Blair PJ; Eberly LE; Maguire J; Ganesan A; Faix D; Duplessis C; Lalani T; Whitman T; Brandt C; Macalino G; Millar EV; Burgess T
    Vaccine; 2011 Apr; 29(17):3183-91. PubMed ID: 21371580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response.
    Aljurayyan A; Puksuriwong S; Ahmed M; Sharma R; Krishnan M; Sood S; Davies K; Rajashekar D; Leong S; McNamara PS; Gordon S; Zhang Q
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher PIK3C2B gene expression of H1N1+ specific B-cells is associated with lower H1N1 immunogenicity after trivalent influenza vaccination in HIV infected children.
    Cotugno N; Zicari S; Morrocchi E; de Armas LR; Pallikkuth S; Rinaldi S; Ruggiero A; Manno EC; Zangari P; Chiriaco M; Bernardi S; Andrews SF; Cagigi A; Rossi P; McDermott AB; Pahwa S; Palma P
    Clin Immunol; 2020 Jun; 215():108440. PubMed ID: 32330555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity.
    Rosendahl Huber SK; Hendriks M; Jacobi RHJ; van de Kassteele J; Mandersloot-Oskam JC; van Boxtel RAJ; Wensing AMJ; Rots NY; Luytjes W; van Beek J
    Front Immunol; 2018; 9():3103. PubMed ID: 30761157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults.
    Hakim H; Allison KJ; Van De Velde LA; Li Y; Flynn PM; McCullers JA
    Vaccine; 2012 Jan; 30(5):879-85. PubMed ID: 22155630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemagglutinin-specific CD4
    Tan S; Zhang S; Wu B; Zhao Y; Zhang W; Han M; Wu Y; Shi G; Liu Y; Yan J; Wu G; Wang H; Gao GF; Zhu F; Liu WJ
    Vaccine; 2017 Oct; 35(42):5644-5652. PubMed ID: 28917539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of functional antibody and memory B-cell responses to pH1N1 monovalent vaccine in HIV-infected children and youth.
    Curtis DJ; Muresan P; Nachman S; Fenton T; Richardson KM; Dominguez T; Flynn PM; Spector SA; Cunningham CK; Bloom A; Weinberg A
    PLoS One; 2015; 10(3):e0118567. PubMed ID: 25785995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.
    Souza TM; Santini-Oliveira M; Martorelli A; Luz PM; Vasconcellos MT; Giacoia-Gripp CB; Morgado M; Nunes EP; Lemos AS; Ferreira AC; Moreira RI; Veloso VG; Siqueira M; Grinsztejn B; Camacho LA
    J Med Virol; 2016 Mar; 88(3):426-36. PubMed ID: 26267817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pandemic influenza A H1N1 vaccine in recipients of solid organ transplants: immunogenicity and tolerability outcomes after vero cell derived, non-adjuvanted, whole-virion vaccination.
    Lagler H; Wenisch JM; Tobudic S; Gualdoni GA; Rödler S; Rasoul-Rockenschaub S; Jaksch P; Redlberger-Fritz M; Popow-Kraupp T; Burgmann H
    Vaccine; 2011 Sep; 29(40):6888-93. PubMed ID: 21803100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans.
    Spensieri F; Siena E; Borgogni E; Zedda L; Cantisani R; Chiappini N; Schiavetti F; Rosa D; Castellino F; Montomoli E; Bodinham CL; Lewis DJ; Medini D; Bertholet S; Del Giudice G
    PLoS One; 2016; 11(6):e0157066. PubMed ID: 27336786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard-Dose Intradermal Influenza Vaccine Elicits Cellular Immune Responses Similar to Those of Intramuscular Vaccine in Men With and Those Without HIV Infection.
    Amoah S; Mishina M; Praphasiri P; Cao W; Kim JH; Liepkalns JS; Guo Z; Carney PJ; Chang JC; Fernandez S; Garg S; Beacham L; Holtz TH; Curlin ME; Dawood F; Olsen SJ; Gangappa S; Stevens J; Sambhara S
    J Infect Dis; 2019 Jul; 220(5):743-751. PubMed ID: 31045222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children.
    Phongsamart W; Sirisanthana V; Wittawatmongkol O; Maleesatharn A; Sudjaritruk T; Chearskul P; Aurpibul L; Sirisanthana T; Chokephaibulkit K
    Vaccine; 2011 Nov; 29(47):8705-11. PubMed ID: 21893147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.